HZNP Key Stats
- Horizon Pharma CEO Discuses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 10
- Horizon Pharma (HZNP) Bests Q1 Loss Views Street Insider May 10
- Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Busin... May 10
- HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Con... May 9
- Horizon Pharma Earnings Preview: Get Ahead of the Analysts May 9
- Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013... Apr 29
- Ask a Fool: Buffett's Biggest Misconception Apr 12
- Horizon Pharma to Present at the 20th Annual Future Leaders in the Biotech Indus... Mar 28
- Whoa! These 3 Stocks Just Beat the Dow Mar 26
- 3 Stocks That Blew the Market Away Mar 25
HZNP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Horizon Pharma is down 36.84% over the last year vs S&P 500 Total Return up 27.96%, Rigel Pharmaceuticals down 38.25%, and Sagent Pharmaceuticals up 10.83%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for HZNP
Pro Report PDF for HZNP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download HZNP Pro Report PDF
Pro Strategies Featuring HZNP
Did Horizon Pharma make it into our Pro Portfolio Strategies?